Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screeningDrug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancerLong-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids
author
type
label
Carla S Verissimo